BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28858994)

  • 1. High plasma concentrations of dolutegravir in patients with ABCG2 genetic variants.
    Tsuchiya K; Hayashida T; Hamada A; Oki S; Oka S; Gatanaga H
    Pharmacogenet Genomics; 2017 Nov; 27(11):416-419. PubMed ID: 28858994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.
    Tandia M; Mhiri A; Paule B; Saffroy R; Cailliez V; Noé G; Farinotti R; Bonhomme-Faivre L
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):759-766. PubMed ID: 28289864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects.
    Prado Y; Zambrano T; Salazar LA
    J Clin Pharm Ther; 2018 Feb; 43(1):87-91. PubMed ID: 28833323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants.
    Tsuchiya K; Hayashida T; Hamada A; Oka S; Gatanaga H
    J Acquir Immune Defic Syndr; 2016 May; 72(1):11-4. PubMed ID: 27097364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation.
    Ueshima S; Hira D; Fujii R; Kimura Y; Tomitsuka C; Yamane T; Tabuchi Y; Ozawa T; Itoh H; Horie M; Terada T; Katsura T
    Pharmacogenet Genomics; 2017 Sep; 27(9):329-336. PubMed ID: 28678049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
    Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
    Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid.
    Choi HY; Bae KS; Cho SH; Ghim JL; Choe S; Jung JA; Jin SJ; Kim HS; Lim HS
    Pharmacogenet Genomics; 2015 Dec; 25(12):595-608. PubMed ID: 26367500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polymorphism of ABCB1 and ABCG2 genes encoding drug transporters and their investigation by pyrosequencing].
    Dribnokhodova OP; Mironov KO; Dunaeva EA; Shipulin GA
    Eksp Klin Farmakol; 2012; 75(10):29-36. PubMed ID: 23240156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants.
    Tsuchiya K; Hayashida T; Hamada A; Kato S; Oka S; Gatanaga H
    J Acquir Immune Defic Syndr; 2014 Aug; 66(5):484-6. PubMed ID: 24872134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of genetic polymorphisms on imatinib concentration and therapeutic response in patients with chronic-phase chronic myeloid leukemia.
    Cheng F; Cui Z; Li Q; Chen S; Li W; Zhang Y
    Int Immunopharmacol; 2024 May; 133():112090. PubMed ID: 38640718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans.
    Kim KA; Cha YJ; Lee HM; Joo HJ; Park JY
    Clin Chim Acta; 2015 Jan; 438():7-11. PubMed ID: 25124867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants in the
    Morau MV; Seguin CS; Visacri MB; Pincinato EC; Moriel P
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of
    Dalle Fratte C; Polesel J; Gagno S; Posocco B; De Mattia E; Roncato R; Orleni M; Puglisi F; Guardascione M; Buonadonna A; Toffoli G; Cecchin E
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study.
    Kopp TI; Andersen V; Tjonneland A; Vogel U
    Scand J Gastroenterol; 2015; 50(12):1469-81. PubMed ID: 26109419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma.
    Kato H; Sassa N; Miyazaki M; Takeuchi M; Asai M; Iwai A; Noda Y; Gotoh M; Yamada K
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):855-62. PubMed ID: 27586968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
    Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H
    Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma.
    Drain S; Flannely L; Drake MB; Kettle P; Orr N; Bjourson AJ; Catherwood MA; Alexander HD
    Leuk Res; 2011 Nov; 35(11):1457-63. PubMed ID: 21705081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Genetic Variants in ABCG2 , NR1I2 , and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children.
    Spector SA; Brummel SS; Chang A; Wiznia A; Ruel TD; Acosta EP;
    J Acquir Immune Defic Syndr; 2024 Mar; 95(3):297-303. PubMed ID: 38180896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study.
    Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A
    J Antimicrob Chemother; 2018 Jun; 73(6):1659-1664. PubMed ID: 29509884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activity of ABCG2, but not ABCB1 or OATP1B1, are associated with cholesterol levels: evidence from in vitro and in vivo experiments.
    To KK; Hu M; Tomlinson B
    Pharmacogenomics; 2014 Jun; 15(8):1091-104. PubMed ID: 25084202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.